Energy logo

Advancing Care for Your Patients With Epilepsy

If you treat patients with epilepsy, the POWER2 study may be an opportunity for those seeking a new investigational treatment option. Vormatrigine, the investigational medicine being studied, is designed to target seizures with a novel mechanism of action.

Connect with our medical team

If you're a US healthcare professional and are interested in speaking with a member of the Praxis medical team to hear more about the study, please provide your contact information.